These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25016699)

  • 21. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
    Manginas A; Bei E; Chaidaroglou A; Degiannis D; Koniavitou K; Voudris V; Pavlides G; Panagiotakos D; Cokkinos DV
    Clin Cardiol; 2005 Apr; 28(4):182-6. PubMed ID: 15869050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.
    Cimmino G; Ragni M; Cirillo P; Petrillo G; Loffredo F; Chiariello M; Gresele P; Falcinelli E; Golino P
    Int J Cardiol; 2013 Sep; 168(2):981-6. PubMed ID: 23157807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB.
    Yang Y; Li G; Zhang R
    Biomed Res Int; 2022; 2022():5984184. PubMed ID: 35028315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
    Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tissue-degrading proteinases and incident cardiovascular disease events.
    Tuomainen AM; Kormi I; Havulinna AS; Tervahartiala T; Salomaa V; Sorsa T; Pussinen PJ
    Eur J Prev Cardiol; 2014 Jul; 21(7):806-12. PubMed ID: 23079500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes.
    Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y
    Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease].
    Chen R; Zhang AR; Zhao XX; Li ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):989-91. PubMed ID: 20113606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study.
    Zhang XW; Ge JB; Yang JM; Ge L; Wang NF; Gao Y; Li PZ; Pan H; Tong GX; Zhou L; Ye XH; Xu J
    Chin Med J (Engl); 2006 Oct; 119(20):1689-94. PubMed ID: 17097015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intravascular ultrasound study of coronary remodeling and determination of matrix metalloproteinase and hypersensitive C-reactive protein].
    Hui B; Dang Q; Wang XF; Jin Z; Xia DS; Gao L; Cai L; Zhang J; Xu F; Wang PX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):428-32. PubMed ID: 15932701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome.
    Hamed GM; Fattah MF
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):705-11. PubMed ID: 25616488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
    Idriss NK; Lip GY; Balakrishnan B; Jaumdally R; Boos CJ; Blann AD
    Thromb Haemost; 2010 Nov; 104(5):1029-37. PubMed ID: 20838751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Associations between the plasma inflammatory markers and plaque morphologies of coronary artery lesions].
    Wang X; Hu DY; Yang SW; Zhang J; Tan C; Zhang SY
    Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):27-30. PubMed ID: 18346322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
    Ma P; Han L; Lv Z; Chen W; Hu H; Tu J; Zhou X; Liu SM
    BMC Cardiovasc Disord; 2016 Feb; 16():29. PubMed ID: 26830193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
    Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
    Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Circulating cytokine measurements by protein chips in patients with acute coronary syndrome].
    Mao H; Liu TZ; Wen M; Chen JJ; Li L; Zhu JK
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):219-22. PubMed ID: 19099977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.